Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sun Pharmaceutical Profit Surges Before Pfizer Settlement Charge
Bloomberg
Friday, August 9, 2013 - 9:41am
tags:
Sun Pharma, earnings, Pfizer
Zogenix Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Friday, August 9, 2013 - 9:40am
tags:
earnings, Zogenix
Pharma professionals feeling angst, but see a few rays of hope
Fierce Pharma
Thursday, August 8, 2013 - 6:56pm
tags:
Big Pharma, patent cliff
Biogen Gains A Leg Up In Fiercely Competitive MS Field
Seeking Alpha
Thursday, August 8, 2013 - 6:54pm
tags:
BiogenIdec, MS, multiple sclerosis, Tecfidera
Medivation Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Thursday, August 8, 2013 - 6:52pm
tags:
earnings, Medivation
Multiple Parties Involved in Potential Onyx Sale, CEO Says
Bloomberg
Thursday, August 8, 2013 - 6:52pm
tags:
ONYX Pharmaceuticals, M&A, Amgen, Bayer
Dendreon says sales of prostate cancer therapy Provenge won't grow in 2013; shares fall
Yahoo/AP
Thursday, August 8, 2013 - 6:50pm
tags:
prostate cancer, Dendreon, Provenge
Impax Laboratories Earnings: Here’s Why Investors are Not Happy Now
Wall St. Cheat Sheet
Thursday, August 8, 2013 - 6:50pm
tags:
Impax Laboratories, earnings
Glaxo Invests in Bioelectronics With New Venture Fund
Bloomberg
Thursday, August 8, 2013 - 2:41pm
tags:
GSK, bioelectronics, venture funds
Former Biotech CEO Asks Supreme Court To Review Free Speech Rights
Pharmalot
Thursday, August 8, 2013 - 2:40pm
tags:
InterMune, idiopathic pulmonary fibrosis, free speech, Actimmune
Acadia Targets Pimavanserin NDA For Late 2014
Seeking Alpha
Thursday, August 8, 2013 - 2:37pm
tags:
pimavanserin, Acadia
Biotech company Intrexon shares surge 38 pct in debut
Reuters
Thursday, August 8, 2013 - 2:27pm
tags:
Intrexon, IPOs
Food Safety Concerns in China Could Fuel Zoetis’ Growth
Motley Fool
Thursday, August 8, 2013 - 2:25pm
tags:
Zoetis, China, animal health
Array BioPharma will cut 20 percent of its jobs
Yahoo/AP
Thursday, August 8, 2013 - 9:03am
tags:
Array Biopharma, layoffs, Amgen
Is There Pipeline Potential in These 3 Biotech Stocks?
Motley Fool
Thursday, August 8, 2013 - 9:02am
tags:
Regeneron, REGN-727, dupilumab, Abexinostat, Pharmacyclics, AVI-7288, Sarepta Therapeutics
Top insulin maker Novo caught up in China's widening drug probes
Yahoo/Reuters
Thursday, August 8, 2013 - 8:59am
tags:
Novo Nordisk, China
Whistle-Blower Alleges Sanofi Bribed Doctors, Herald Says
Bloomberg
Thursday, August 8, 2013 - 8:58am
tags:
whistleblowers, Sanofi, China
A.P. Pharma, Inc. Announces Planned Name Change to “Heron Therapeutics, Inc.” and Application to List on NASDAQ Capital Market
Yahoo
Thursday, August 8, 2013 - 8:39am
tags:
AP Pharma, Heron Therapeutics, NASDAQ
Generic Drugmakers Face An Increasingly Uncertain World: Moody's
Pharmalot
Thursday, August 8, 2013 - 8:33am
tags:
generics, Mylan, Novartis, Supreme Court, Teva, Actavis
Pfizer Moves Up In Market Cap Rank, Passing IBM
Forbes
Thursday, August 8, 2013 - 8:14am
tags:
Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.